Skip to main content

Advertisement

ADVERTISEMENT

News

News
02/16/2023
Approximately 9.5 million people in the U.S. are projected to have AFib in 2023, with the number expected to rise to approximately 12.1 million by 2030; many ignore their symptoms, not realizing that AFib increases their risk of stroke by...
Approximately 9.5 million people in the U.S. are projected to have AFib in 2023, with the number expected to rise to approximately 12.1 million by 2030; many ignore their symptoms, not realizing that AFib increases their risk of stroke by...
Approximately 9.5 million people...
02/16/2023
EP Lab Digest
News
02/14/2023
Asundexian is an oral inhibitor of Factor XIa that Bayer is developing as a potential treatment for prevention of stroke in atrial fibrillation, as well as for secondary prevention in patients with a non-cardioembolic ischemic stroke...
Asundexian is an oral inhibitor of Factor XIa that Bayer is developing as a potential treatment for prevention of stroke in atrial fibrillation, as well as for secondary prevention in patients with a non-cardioembolic ischemic stroke...
Asundexian is an oral inhibitor...
02/14/2023
Cath Lab Digest

Advertisement

News
02/13/2023
Cardiovascular diseases affects over 3 million Canadians, and over 750, 000 Canadians are living with heart failure. Almost 1 in 3 Canadians are touched by heart failure, and over 100,000 new Canadians are diagnosed with heart failure every...
Cardiovascular diseases affects over 3 million Canadians, and over 750, 000 Canadians are living with heart failure. Almost 1 in 3 Canadians are touched by heart failure, and over 100,000 new Canadians are diagnosed with heart failure every...
Cardiovascular diseases affects...
02/13/2023
EP Lab Digest
News
02/13/2023
Veradigm®, a leading provider of healthcare data and technology solutions, and HealthVerity®, a leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data, announced a collaboration that will advance real-world research...
Veradigm®, a leading provider of healthcare data and technology solutions, and HealthVerity®, a leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data, announced a collaboration that will advance real-world research...
Veradigm®, a leading provider of...
02/13/2023
EP Lab Digest
News
02/13/2023
Acquisition supports GE HealthCare’s $3 billion Ultrasound business by adding AI-enabled image guidance to ultrasound device portfolios Helps enable affordable, convenient access to point of care ultrasound imaging for a variety of...
Acquisition supports GE HealthCare’s $3 billion Ultrasound business by adding AI-enabled image guidance to ultrasound device portfolios Helps enable affordable, convenient access to point of care ultrasound imaging for a variety of...
Acquisition supports GE...
02/13/2023
EP Lab Digest

Advertisement

News
02/09/2023
This “Galentine’s Day,” Feb 13, a new fundraiser allows people around the country to support women’s heart health research at Cleveland Clinic.
This “Galentine’s Day,” Feb 13, a new fundraiser allows people around the country to support women’s heart health research at Cleveland Clinic.
This “Galentine’s Day,” Feb 13,...
02/09/2023
Cath Lab Digest
News
02/09/2023
Drinking coffee helps maintain low blood pressure. People who drink two or three cups of coffee a day have lower blood pressure than those who drink just one cup or none at all. This applies both to peripheral and...
Drinking coffee helps maintain low blood pressure. People who drink two or three cups of coffee a day have lower blood pressure than those who drink just one cup or none at all. This applies both to peripheral and...
Drinking coffee helps...
02/09/2023
Cath Lab Digest
News
02/09/2023
DUBLIN and DALLAS – February 8, 2023 – Medtronic announced late-breaking clinical data from the STROKE AF clinical study, which showed large and small vessel disease stroke patients had a 10-fold increase in AF detection with the Reveal...
DUBLIN and DALLAS – February 8, 2023 – Medtronic announced late-breaking clinical data from the STROKE AF clinical study, which showed large and small vessel disease stroke patients had a 10-fold increase in AF detection with the Reveal...
DUBLIN and DALLAS –...
02/09/2023
Cath Lab Digest

Advertisement

News
02/08/2023
MENLO PARK, Calif., Feb. 3, 2023 /-- Ablacon, Inc., an Ajax Health and Zeus Health-backed developer of an innovative mapping system to guide the treatment of atrial fibrillation (AF), announced today the 12-month results from...
MENLO PARK, Calif., Feb. 3, 2023 /-- Ablacon, Inc., an Ajax Health and Zeus Health-backed developer of an innovative mapping system to guide the treatment of atrial fibrillation (AF), announced today the 12-month results from...
MENLO PARK, Calif., Feb. 3,...
02/08/2023
EP Lab Digest
News
02/08/2023
The OCEANIC program will investigate the efficacy and safety of asundexian (BAY2433334) in the prevention of stroke in patients with atrial fibrillation and also patients with a non-cardioembolic ischemic stroke or high-risk transient...
The OCEANIC program will investigate the efficacy and safety of asundexian (BAY2433334) in the prevention of stroke in patients with atrial fibrillation and also patients with a non-cardioembolic ischemic stroke or high-risk transient...
The OCEANIC program will...
02/08/2023
EP Lab Digest

Advertisement